1. Australian Injectable Drug Handbook 3rd Ed, The Society of Hospital Pharmacists of Australia 2005.
2. Mims, http://mims.hcn.net.au/ifmx-nsapi/mims-data/?MIval=2MIMS_ssearch (2007).
3. 1974 - 2004 Thomson MICROMEDEX. All rights reserved. MICROMEDEX(R) Healthcare Series Vol. 120 expires 6/2004
4. Therapeutic Guidelines: Cardiovascular: Management of pre-eclampsia http://etg.hcn.net.au/
|
5. Paterson-Brown S, Robson SC, Redfern N, Walkinshaw SA et al. Hydralazine boluses for the treatment of severe hypertension in pre-eclampsia. J Obstet Gynae 1994; 101: 409-413.
6. Magee LA, Cham C, Waterman EJ, Ohlsson A et al. Hydralazine for treatment of severe hypertension in pregnancy : meta-analysis. BMJ.COM. 2003; 327: 955
7. Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev. 2006 Jul 19;3:CD001449. Review.
8. Begum MR. Quadir E. Begum A. Akhter S. Rahman K. Management of hypertensive emergencies of pregnancy by hydralazine bolus injection vs continuous drip--a comparative study. Medscape Womens Health. 7(5):1, 2002.
9. Vigil-De Gracia P, Lasso M, Ruiz E, Vega-Malek J, de Mena F, López J. Severe hypertension in pregnancy: Hydralazine or labetalol - A randomized clinical trial. European Journal of Obstetrics & Gynecology and Reproductive Biology, Volume 128, Issue 1-2, Pages 157-162
|
Revised and updated: 5 November 2007
|
Royal Women's Hospital Clinical Practice Guidelines (CPGs) are intended to provide guidance to health care professionals, based on a thorough evaluation of research evidence, on the practical assessment and management of specific clinical issues or situations. The guidelines allow some flexibility on the part of the health care professional based on the needs of the specific patient for whom they are caring.
|
Please remember to read our disclaimer.
|
